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Host resistance to viral infection requires type I (a/b)
and II (g) interferon (IFN) production. Another impor-
tant defensemechanism is the degradative activity of
macroautophagy (herein autophagy), mediated by
the coordinated action of evolutionarily conserved
autophagy proteins (Atg). We show that the Atg5-
Atg12/Atg16L1 protein complex, whose prior known
function is in autophagosome formation, is required
for IFNg-mediated host defense against murine nor-
ovirus (MNV) infection. Importantly, the direct anti-
viral activity of IFNg against MNV in macrophages
required Atg5-Atg12, Atg7, and Atg16L1, but not
induction of autophagy, the degradative activity of
lysosomal proteases, fusion of autophagosomes
and lysosomes, or the Atg8-processing protein
Atg4B. IFNg, via Atg5-Atg12/Atg16L1, inhibited
formation of the membranous cytoplasmic MNV
replication complex, where Atg16L1 localized.
Thus, the Atg5-Atg12/Atg16L1 complex performs
a pivotal, nondegradative role in IFNg-mediated anti-
viral defense, establishing that multicellular organ-
isms have evolved to use portions of the autophagy
pathway machinery in a cassette-like fashion for
host defense.
INTRODUCTION
Previous work using mice lacking the interferon (IFN) a/b
receptor, the IFNg receptor, or both receptors has shown that
when compensatory IFNa/b responses are absent, IFNg isCell Hessential for host defense against acute infection with both
RNA and DNA viruses (Gil et al., 2001; Karst et al., 2003). Further-
more, IFNg has direct antiviral activity against many viruses,
including single-stranded positive-sense RNA viruses (Kimura
et al., 1994; Shrestha et al., 2006). The antiviral role of IFNg likely
provides a host counterpoint to the capacity of many viruses to
inhibit the antiviral activities of IFNa/b using highly evolved
immune evasion strategies. Autophagy and autophagy proteins
play important roles in host defense against infection, develop-
ment, cellular energy homeostasis, and multiple diseases,
including cancer and inflammatory bowel disease (Levine
et al., 2011). Since autophagy proteins expressed by macro-
phages, which are key innate immune cells, have a role in
IFNg-mediated resistance to both mycobacteria and the api-
complexan parasite Toxoplasma gondii (Levine et al., 2011;
Zhao et al., 2008), we hypothesized that autophagy proteins
also participate in the antiviral activities of IFNg.
The degradative function of the overall autophagy pathway
involves delivery of cytoplasmic cargo contained within double
membrane-bound autophagosomes to the lysosome. This
process requires the ordered activity of protein complexes
that induce autophagosome formation, envelopment of specific
cargoes or bulk cytoplasm, elongation and closure of autopha-
gosome membranes, fusion of the outer autophagosomal
membrane to the lysosome, and degradation of cargo within
the autophagosome by lysosomal enzymes active at low pH
(Levine et al., 2011). One protein complex required for autoph-
agy contains Atg16L1 bound to a covalent Atg5-Atg12 conju-
gate that is generated by the action of Atg7. The known activity
of this complex is to promote elongation and closure of the
autophagosome via an E3-ligase-like role in the generation of
lipidated forms of LC3 (microtubule-associated protein 1 light
chain 3, Atg8) family proteins and their localization to the
autophagosome membrane (Weidberg et al., 2010; Fujita
et al., 2008b). LC3 proteins are processed in preparation forost & Microbe 11, 397–409, April 19, 2012 ª2012 Elsevier Inc. 397
Figure 1. Atg5WasRequired for IFNg-Medi-
ated Suppression of MNV Both In Vivo and
In Vitro
(A and B) Survival curves after per oral inoculation
with 3 3 104 pfu of MNV. The number of mice
used is indicated in parentheses. Experimental
groups were compared to C57BL/6 controls (A).
Atg5-deficient mice were compared to control
mice (B).
(C and D) Growth analysis of MNV in control
(circle; Atg5flox/flox) and Atg5-deficient (square;
Atg5flox/flox+LysMcre) macrophages after pre-
treatment with none (filled) or 100 U/ml IFNg
(open) for 12 hr before infection at MOI = 5 (C) and
0.05 (D). Mean virus titers ± SEM from three
independent experiments (n = 3) are shown.
See also Figure S1.
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in˜o et al., 2010).
Noroviruses cause the majority of human nonbacterial
epidemic gastroenteritis and are a major cause of food-borne
illness and human morbidity (Glass et al., 2009). Relatively little
is known about themechanisms of host resistance for this impor-
tant class of pathogens. While human noroviruses have not been
cultured efficiently and do not infect small animals, murine noro-
virus (MNV) can be cultured in macrophages and thus provides
amodel of infection for this important genus of human pathogens
(Glass et al., 2009; Wobus et al., 2004; Karst et al., 2003). The
replication of MNV in macrophages is, as for other single-
stranded positive-sense RNA viruses, associated with extensive
membrane rearrangements that generate membranous replica-
tion complexes within which viral RNAs and proteins are
produced and assembled into infectious virions (Hyde et al.,
2009;Wobus et al., 2004). Using theMNVmodel, we investigated
the role of the autophagy pathway and protein components of
the autophagy machinery in host antiviral defense. We show
here that IFNg-activated macrophages use portions of the au-
tophagy machinery, in a cassette-like fashion, to block norovirus
infection by inhibiting formation of the replication complex.
RESULTS
Atg5 Protects against Lethal MNV Infection in the
Absence of IFNa/b Signaling
To test the hypothesis that autophagy proteins are involved
in IFNg-mediated antiviral defense, we analyzed the role of398 Cell Host & Microbe 11, 397–409, April 19, 2012 ª2012 Elsevier Inc.Atg5 in control of disease induced by
the enteric pathogen MNV. We first
confirmed that mice lacking both
IFNa/b and IFNg receptors (IFNa/b/
gR/) succumb to lethal infection with
3 3 104 plaque forming units (pfu) of
MNV (Figure 1A) (Karst et al., 2003;
Mumphrey et al., 2007). In contrast,
mice lacking either the IFNa/bR or the
IFNgR alone are resistant to lethal MNV
infection (Figure 1A). These data indicatethat IFNa/b and IFNg share overlapping but nonredundant
roles in defense against MNV. As for many viruses, the antiviral
role of IFNg, and therefore proteins required for IFNg control of
MNV infection in vivo, may then be detected when compensa-
tory IFNa/b responses are absent. Atg5 is essential for auto-
phagosome formation and Atg5-deficient mice die soon after
birth (Levine et al., 2011). To test the role of Atg5 in IFNg-
dependent resistance to MNV infection, we generated IFNa/
bR/ mice lacking Atg5 in macrophages and neutrophils
that express lysozyme M. We crossed Atg5flox/flox mice ex-
pressing lysozyme-M promoter driven cre-recombinase
(Atg5flox/flox+LysMcre) (Zhao et al., 2008; DeSelm et al., 2011)
to IFNa/bR/ mice, generating IFNa/bR/ x Atg5flox/flox+
LysMcre mice. We then compared MNV infection of IFNa/
bR/ x Atg5flox/flox+LysMcre mice to infection of control
IFNa/bR/ x Atg5flox/flox mice. Mice deficient in Atg5 in macro-
phages and neutrophils succumbed to lethal MNV infection
while control mice did not (Figure 1B). While MNV replication
is confined to certain tissues (mesenteric lymph node, intes-
tine, spleen, and liver) in immune-competent mice, MNV repli-
cation is widely disseminated in immune-compromised mice
(Karst et al., 2003; Mumphrey et al., 2007). Consistent with
this, MNV replication was significantly increased in all tissues
examined from IFNa/bR/ x Atg5flox/flox+LysMcre mice
compared to tissues of control IFNa/bR/ x Atg5flox/flox mice
(Figures S1A–S1F available online). These data demonstrate
that Atg5 expression in macrophages and/or neutrophils was
essential for control of MNV infection in mice with compro-
mised IFNa/b signaling.
Figure 2. Transcriptional Analysis of IFNg-Treated
Control and Atg5-Deficient Macrophages
(A) Schematic diagram of transcript analysis in control and
Atg5-deficient macrophages with and without IFNg treat-
ment using microarrays.
(B) Transcriptional profiles induced by IFNg treatment of
control and Atg5-deficient macrophages. x axis: the ratio
(in log2 scale) of fold changes induced in IFNg-treated
Atg5-deficient cells to fold changes induced in IFNg-
treated control macrophages. y axis: the significance
(p values in –log10 scale) of the difference in means of fold
change induction.
See also Figure S2 and Table S1.
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Dependent
To explain this profound in vivo phenotype, we hypothesized that
Atg5 is required for the direct antiviral effects of IFNg against
MNV in macrophages, a cell type in which MNV replicates (Wo-
bus et al., 2004). Bone marrow-derived macrophages were
prepared from Atg5flox/flox+LysMcre (henceforth Atg5-deficient)
and Atg5flox/flox (henceforth control) mice and inoculated with
MNV at high (5) or low (0.05) multiplicity of infection (MOI). No
significant differences in MNV replication were observed
between control and Atg5-deficient macrophages (Figures 1C
and 1D). However, pretreatment with IFNg inhibited MNV repli-
cation by >100–1000 fold in control macrophages but not inCell Host & Microbe 11Atg5-deficient macrophages (p < 0.05 [Fig-
ure 1C] and p < 0.01 [Figure 1D]). In contrast,
pretreatment with IFNb suppressed MNV repli-
cation equally in control and Atg5-deficient
macrophages (Figure S1G). Thus, Atg5 was
not required for the replication of MNV, but
was critical for the IFNg-mediated control of
MNV replication in macrophages.
Atg5 Is Not Required for IFNg-Mediated
Cellular Transcriptional Changes
The antiviral effects of IFNg depend on the
expression of IFN-stimulated genes via the
Janus-activated kinase (JAK)-signal transducer
and activator of transcription (STAT) signaling
pathway. It has been reported that autophagy
protein-deficient but transformed murine fibro-
blast cells exhibit abnormal IFNg-induced
JAK-STAT activation (Chang et al., 2010).
Therefore, we used microarrays to measure
transcript levels in control and Atg5-deficient
primary macrophages with or without IFNg
treatment (Figure 2 and Table S1). While IFNg
induced major changes in cellular transcription
as expected, no statistically significant differ-
ences were observed in the transcriptional
profiles induced by IFNg treatment of control
and Atg5-deficient macrophages (Figure 2B).
When evaluating the fold change of induced
genes between IFNg treated control and Atg5-
deficient macrophages, there were some genesthat exceeded either the biological relevance threshold [shown
on the x axis as log2 (fold-change-ratio) >1 or <1; indicated
by vertical dashed lines] or the statistical significance threshold
[shown on the y axis as significance >–log10 (0.05); indicated
by horizontal dashed line]. However, none of these genes ex-
ceeded both thresholds (Figure 2B). These data demonstrate
that IFNg-mediated transcriptional modulation in macrophages
is not Atg5 dependent. We also considered the possibility that
Atg5 deficiency resulted in the general disruption of cell homeo-
stasis or IFNg-mediated activation of macrophages. However,
Atg5-deficient macrophages had normal levels of ATP (Fig-
ure S2A), exhibited normal phosphorylation of STAT1 and induc-
tion of IRF1 protein (Figure S2B), and were able to inhibit the, 397–409, April 19, 2012 ª2012 Elsevier Inc. 399
Figure 3. Catabolic Autophagy Was Not Required for the IFNg-Mediated Suppression of MNV Replication
(A) Flow cytometry analysis of MNV replication (n = 3) at 12 hpi (MOI = 5) upon treatment with autophagy modulatory drugs. Chloroquine (CHQ, 20 mM),
rapamycin (Rapa, 10 mM), wortmannin (WORT, 50 nM), or none (UN). Top: Representative flow data of MNV replication after no treatment (–IFNg) or 100 U/ml
of IFNg pretreatment (+IFNg) for 12 hr. Bottom: Quantitation of relative MNV replication after normalization to the level in untreated BMDMs. * indicates
statistically significant difference (p < 0.05) compared to the untreated (100%). This convention is carried through all figures. Mean virus titers ± SEM from
three independent experiments (n = 3) are shown.
(B) Growth analysis of MNV (n = 3) in drug-treated BMDMs at 24 hpi (MOI = 0.05). n.s. indicates no statistically significant difference among samples (p > 0.05).
(C) Same analysis (n = 2) shown in (A) with more autophagy-modulating drugs: EBSS (Earle’s balanced salt solution), BafilomycinA1 (100 nM), E64D/PepstatinA
(10 mg/ml), LY294002 (10 mM).
(D) Same analysis (n = 2) shown in (B) with the drugs shown.
(E) Flow cytometry analysis of MNV replication (n = 3) upon the expression of dominant negative forms of autophagy proteins.
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and West Nile virus in response to treatment with IFNg (Figures
S2D–S2F). While canonical autophagy can play an important
role in cell homeostasis upon various cellular stress or stimula-
tion (Stephenson et al., 2009; Saitoh et al., 2008; Tal et al.,
2009; Chang et al., 2010; Levine et al., 2011), these data suggest,
consistent with studies in osteoclasts (DeSelm et al., 2011), that
there is no general disruption of cellular homeostasis in Atg5-
deficient macrophage lineage cells. Importantly, the capacity
of Atg5-deficient cells to control the replication of other viruses
in response to IFNg strongly argues against the possibility that
the lack of IFNg effects on MNV replication in these cells is
due to a combination of minor disruptions in cell homeostasis.
Together, these data indicate that IFNg-mediated inhibition of
MNV replication occurs via a non-transcriptional function of
Atg5, and there is no general disruption of cellular responses
to IFNg in the absence of Atg5.
The Catabolic Activity of the Autophagy Pathway Is Not
Required for Control of MNV by IFNg
Since Atg5 is essential for autophagy, we examined whether
IFNg inhibits the replication of MNV in macrophages through
the modulation of the canonical autophagy pathway. To monitor
the flux of the autophagy pathway in response to IFNg, we
analyzed the conversion (lipidation) of LC3-I (unconjugated) to
LC3-II (conjugated to phosphatidylethanolamine) in the pres-
ence and absence of chloroquine. Chloroquine blocks the
degradation of LC3-II that occurs after fusion of lysosomes
and autophagosomes (Mizushima et al., 2010). Treatment of
macrophages with chloroquine led to the accumulation of
LC3-II (Figure S3A). As a control we showed that the autoph-
agy-inducing drug rapamycin increased the conversion of
LC3-I to LC3-II, and accumulation of LC3-II in combination
with chloroquine, in treated cells compared to untreated cells
(Mizushima et al., 2010). In contrast, neither high (100 U/ml)
nor low (1 U/ml) doses of IFNg affected the conversion of
LC3-I to LC3-II, suggesting that effects of IFNg on MNV replica-
tion are not associated with significant changes in bulk autoph-
agy. It has been shown that IFNg induces autophagy in cell lines
and that autophagy facilitates IFNg-induced Jak2-STAT1
signaling in specific transformed cell lines by negatively regu-
lating reactive oxygen species (ROS) (Levine et al., 2011; Del-
gado et al., 2008; Chang et al., 2010). However, in primarymouse
macrophages, we did not detect a significant difference in IFNg
signaling in the absence of Atg5 (Figures 2 and S2B) and IFNg did
not significantly induce autophagy (Figure S3A). Furthermore,
downregulation of ROS using antioxidant treatment (Tal et al.,
2009) did not effect IFNg-mediated control of MNV replication
(Figure S2C). This discrepancy between our findings and pub-
lished data may be due to differences in experimental design or
to differences between primary cells and transformed cell lines.
Next, we directly examined whether inducing or inhibiting au-
tophagy would alter MNV replication or its control by IFNg. To
analyze the replication of MNV in macrophages within a single(F) Growth analysis of MNV (n = 3) in the transduced BMDMs.
(G) Flow cytometry analysis of MNV replication (n = 2) in control and Atg4BKO B
(H) Growth analysis of MNV (n = 2) in control and Atg4BKO BMDMs.
In all graphs, data represent mean ± SEM. See also Figure S3.
Cell Hreplication cycle, we developed a flow cytometry-based assay
in which cells were inoculated with MNV (MOI = 5) and stained
with an antibody to theMNV polymerase (Figure S3B). Treatment
of macrophages with rapamycin, chloroquine (blocks lysosomal
degradation), or wortmannin (inhibits the initiation of autophagy
in nutrient-rich conditions (Wu et al., 2010) either before or after
viral infection had the expected effects on autophagy (Fig-
ure S3G) but did not significantly affect MNV replication or its
control by IFNg (Figures 3A and 3B). To examine the role of later
steps in canonical autophagy in antiviral activity mediated by
IFNg, we used lentiviral transduction to overexpress a dominant
negative form of ras-related protein 7A (Rab7A/T22N), which
blocks fusion of autophagosomes and lysosomes, as well as
bacterial autophagy (Yamaguchi et al., 2009). As expected,
Rab7/T22N expression inhibited degradative autophagy leading
to the accumulation of p62, which is a well-known substrate
degraded through autophagy (Figure S3C). However, this inhib-
itor of degradative autophagy did not prevent IFNg-mediated
control of MNV replication (Figures 3E and 3F). Similarly, inhibi-
tors of lysosomal proteases or lysosomal acidification (E64D/
PepstatinA and BafilomycinA1) blocked the degradative activity
of the autophagy pathway (Figure S3G) but did not block the
antiviral effects of IFNg against MNV (Figures 3C and 3D).
Further, induction or inhibition of autophagy initiation (starvation,
wortmannin, LY294002) also did not significantly affect the IFNg-
mediated control of MNV replication (Figures 3C and 3D). Lastly,
protein kinase R (PKR) is involved in autophagic control of herpes
simplex virus replication (Levine et al., 2011), but PKR was not
required for IFNg-mediated blockade of MNV replication (Fig-
ure S3D). Taken together, these data demonstrated that, while
Atg5 is required for IFNg-mediated inhibition of MNV replication,
the degradative autophagy pathways, as well as other pathways
known to be involved in the antiviral effects of autophagy, were
not involved in the control of MNV replication by IFNg.
Atg12 Conjugation to Atg5 Is Required
for IFNg-Mediated Control of MNV
To define the molecular basis for the required role for Atg5 in
IFNg-mediated inhibition of MNV replication, we reconstituted
Atg5-deficient macrophages by expressing wild-type and
mutant forms of Atg5 (Figure 4E). Atg5 functions in autophagy
as a covalent conjugate with Atg12. To examine the role of
Atg5-Atg12 conjugation, we expressed Atg5/K130R, which
cannot be conjugated to Atg12 (Levine et al., 2011). Expression
of Atg5 in Atg5-deficient macrophages significantly restored
expression of the Atg5-Atg12 conjugate, the conversion of
LC3-I to LC3-II, and reduction of p62 level (Figure 4E). In
contrast, expression of Atg5/K130R generated an unconjugated
form of Atg5, did not restore the conversion of LC3-I to LC3-II
and increased, rather than decreased, the level of p62. IFNg sup-
pressed the replication of MNV in all lentivirus-transduced
control macrophages (Figures 4A and 4B). Importantly, while
Atg5 reconstituted IFNg control of MNV replication in Atg5-defi-
cient macrophages, Atg5/K130R did not (Figures 4C and 4D),MDMs.
ost & Microbe 11, 397–409, April 19, 2012 ª2012 Elsevier Inc. 401
Figure 4. Specific Requirement of Atg5 and Atg12 Conjugation in the IFNg-Mediated Suppression of MNV Replication
(A and C) Flow cytometry analysis of MNV replication and its control by IFNg (n = 5) in control (A) and Atg5-deficient (C) macrophages at 12 hpi (MOI = 5) upon the
expression of Atg5 or Atg5/K130R. Right: A representative flow data. Left: Quantitation of relative MNV replication.
(B&D) Growth analysis of MNV (n = 5) in transduced control (B) and Atg5-deficient (D) macrophages at 24 hpi (MOI = 0.05).
(E) A representative western blot analysis of autophagy status in macrophages (n = 3) after lentiviral transduction with control, Atg5, or Atg5/K130R. The
arrowhead indicates the uncleaved form of Atg5/K130R-T2A-copGFP.
(F) Flow cytometry analysis (n = 3) of MNV replication and its control by IFNg (10 U/ml) in control (Atg7flox/flox) and Atg7-deficient (Atg7flox/flox+LysMcre)
macrophages at 12 hpi (MOI = 5). Top: Representative flow data. Bottom: Quantitation of relative MNV replication.
In all graphs, data represent mean ± SEM. See also Figure S4.
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inhibition of MNV replication.
Atg16L1 Is Required for IFNg-Mediated Suppression
of MNV
The Atg5-Atg12 conjugate plays its role in autophagy as part of
a complex that includes Atg16L1 (Levine et al., 2011). We there-
fore determined whether the binding of Atg5-Atg12 to Atg16L1
was required for IFNg-mediated control of MNV using two
approaches. First, based on the structure of the yeast Atg5
and Atg16L1 complex (Matsushita et al., 2007), we generated
Atg16L1 binding-defective mutants of Atg5. Several single
amino acid substitutions in Atg5 (R41A, G84A, D88A, G242A)
reduced the binding of Atg5 to Atg16L1, but none of them
completely blocked the interaction (Figure S4B). Therefore, we
made an Atg5/G84A/D88A mutant combining two single amino
acid substitutions, and we observed that this mutant exhibited
a substantial deficit in Atg16L1 binding (Figure S4B). We then
tested the effects of two Atg5 mutants, with differing ability to
bind Atg16L1, in control and Atg5-deficient macrophages. In
control macrophages, neither mutant significantly affected the
replication of MNV or its control by IFNg (Figures 5A and 5B).
However, in Atg5-deficient macrophages Atg5/D88A partially
restored the control of MNV replication by IFNg but Atg5/G84A/
D88A did not (Figures 5C and 5D). Although we cannot rule out
the possibility that this partial restoration by Atg5/G84A but not
by Atg5/G84A/D88A might be caused by differences in expres-
sion (Figure S4C), given their differing capacity to bind Atg16L1
(Figure S4B), these data suggest that Atg5 binding to Atg16L1
was also required for IFNg to control MNV replication.
To directly investigate the necessity of Atg16L1 for the antiviral
function of IFNg, we generated a conditional knockout (KO) allele
of mouse Atg16L1 and deleted Atg16L1 specifically in macro-
phages using LysMcre (Atg16flox/flox+LysMcre). Autophagy was
defective in Atg16L1-deficient macrophages (e.g., accumulation
of p62), but expression of wild-type Atg16L1 in the Atg16L1-defi-
cient macrophages restored autophagy (Figure S4D). Similar to
Atg5-deficient macrophages, MNV replication was controlled
by IFNg in control macrophages (Figures 5E and 5F) but not in
Atg16L1-deficient macrophages (Figures 5G and 5H). However,
upon reintroduction of Atg16L1 in Atg16L1-deficient macro-
phages, MNV replication was controlled by IFNg treatment.
These data demonstrate that Atg16L1 was required for IFNg to
control MNV replication. Taken together, the data shown in
Figures 4 and 5 indicate that the Atg5-Atg12/Atg16L1 protein
complex is required for IFNg to control MNV replication.
Atg7 Is Required for IFNg-Mediated Suppression ofMNV
through Generation of the Atg5-Atg12 Conjugate
Since Atg7 is the enzyme responsible for Atg5-Atg12 conjuga-
tion (Levine et al., 2011), we determined the requirement for
Atg7 in IFNg-mediated inhibition of MNV replication using
Atg7-deficient macrophages derived by crossing Atg7flox/flox
mice to LysMcre mice (DeSelm et al., 2011) (Figure S4A). There
was no significant difference in MNV replication between control
and Atg7-deficient macrophages (Figure 4F). However, IFNg-
mediated inhibition of MNV replication required Atg7 (Figure 4F).
In addition to generating the Atg5-Atg12 conjugate, Atg7 partic-
ipates in canonical autophagy through its required role in the lip-Cell Hidation of LC3 family members. To determine the role of this
function in control of MNV replication, we studied macrophages
lacking LC3b (Cann et al., 2008), but we detected no effect of
LC3b deficiency on either growth of MNV or the effect of IFNg
onMNV replication (Figure S3E). The lack of a role for LC3bmight
be explained by the extensive redundancy of LC3 family
members (Reggiori et al., 2010; Weidberg et al., 2010). There-
fore, we examined the role of Atg4B, which is the predominant
Atg4 family member involved in canonical autophagy via its
role in preparing LC3 proteins for conjugation to phosphatidyl-
ethanolamine through proteolytic processing. Accordingly, we
overexpressed the dominant negative form of Atg4B (AtgB/
C74A) (Fujita et al., 2008a), which blocks the proper processing
and lipidation of LC3 proteins. As expected, this protein inhibited
autophagy (Figure S3C). However, expression of this dominant
negative form of Atg4B had no significant effect on MNV replica-
tion or its control by IFNg (Figures 3E and 3F). Furthermore,
Atg4B deficient macrophages isolated frommutantmice (Marin˜o
et al., 2010) exhibited a striking deficiency in autophagy (Fig-
ure S3F), but exhibited no significant change in MNV replication
or the control of MNV replication by IFNg (Figures 3G and 3H).
These data indicate that a highly selective portion of the autoph-
agy machinery, including only one of the two known activities of
Atg7, is required for the antiviral effects of IFNg against MNV
replication.
Atg16L1 Is Specifically Localized in theMNVReplication
Complex
To further understand the role of Atg5-Atg12/Atg16L1 and Atg7
in IFNg-mediated inhibition of MNV replication, we investigated
the localization of epitope tagged Atg5, Atg12, and Atg16L1 in
murine embryonic fibroblast (MEF) cells transfected with
a plasmid that expresses the nonstructural proteins of MNV.
We utilized this system because localizing endogenous autoph-
agy proteins in infected macrophages has been difficult using
the antibodies available. We confirmed that IFNg inhibits the
replication of MNV in MEFs in an Atg5-dependent manner (Fig-
ure S5A). In wild-type MEFs, Atg5 and Atg12 were localized
throughout the cell (Figures 6A and 6B), while Atg16L1 had
a punctate localization, which colocalized with the MNV poly-
merase (Figure 6C). Interestingly, this colocalization of Atg16L1
with the MNV polymerase was also detected in Atg5 KO and
Atg7 KO MEFs (Figure S5E). Although it is not clear whether
Atg5 and Atg12 specifically colocalize with the MNV polymerase
due to their diffuse cytoplasmic localization, the punctate local-
ization of Atg16L1 with the MNV polymerase strongly suggests
that Atg16L1 localizes on the MNV replication complex. To
examine this colocalization at high resolution, we used
stochastic optical reconstruction microscopy (STORM), a
nanometer-resolution fluorescence microscopy method that is
based on high-accuracy localization of photoswitchable fluoro-
phores (Rust et al., 2006). Using STORM, we confirmed that
Atg16L1 colocalized and was tightly coassociated with the
MNV polymerase (Figure 6D). Interestingly, we observed a spec-
trum of colocalization between Atg16L1 and the MNV poly-
merase with the two proteins in some cases closely adjacent
but separated while in other cases they were comingled (Fig-
ure 6D and Movie S1). These localization data place a protein,
Atg16L1, which is required for the blockade of MNV replicationost & Microbe 11, 397–409, April 19, 2012 ª2012 Elsevier Inc. 403
Figure 5. Atg16L1 Was Required for the IFNg-Mediated Suppression of MNV Replication
(A and C) Flow cytometry analysis (n = 3) of the effect of Atg16L1 binding-defective Atg5 mutants (D88A and G84A/D88A) on MNV replication and its control by
IFNg in transduced control (A) and Atg5-deficient (C)macrophages at 12 hpi (MOI = 5). Top: Representative data. Bottom: Quantitation of relativeMNV replication.
(B and D) Growth analysis of MNV (n = 3) in the transduced control (B) and Atg5-deficient (D) macrophages at 24 hpi (MOI = 0.05).
(E and G) Flow cytometry analysis (n = 3) of the replication of MNV and its control by IFNg in control (E; Atg16flox/flox) and Atg16L1-deficient (G; Atg16flox/flox+
LysMcre) macrophages at 12 hpi of MOI = 5. Right: Representative data. Left: Quantitation of relative MNV replication.
(F and H) Growth analysis of MNV (n = 3) in transduced control (F) and Atg16L1-deficient (H) macrophages at 24 hpi (MOI = 0.05).
In all graphs, data represent mean ± SEM. See also Figure S4.
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Figure 6. The Localization of Atg5, Atg12, and
Atg16L1 in Relation to MNV Replication Complex
(A–C) Conventional immunofluorescence microscopy
image of FLAG-tagged Atg5 (A), Atg12 (B), and Atg16L1
(C) in relation to MNV replication complex (as propol+) in
cotransfected MEFs.
(D) High-resolution STORM images of FLAG-Atg16L1 and
MNV replication complex in cotransfected MEFs. The
scale bars inside images represent 100 nm, except the
leftmost images (2 mm).
See also Figure S5 and Movie S1.
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Atg5-Atg12/Atg16L1 Complex in Antiviral Immunityby IFNg, at the MNV replication complex, a membranous struc-
ture required for viral replication.
Atg5 Is Required for IFNg to Prevent MNV from Forming
Replication Complex
To understand this mechanism of Atg5-Atg12/Atg16L1-depen-
dent inhibition of MNV replication, we first defined the stage of
the MNV life cycle at which IFNg exerts Atg5-dependent antiviral
effects, focusing on steps in the life cycle upstream and down-
stream of the formation of the replication complex (flow chart
in Figure 7A). As observed in a previous study, expression of
the nonstructural MNV polymerase in untreated control macro-
phages was detected by western blot by 5 to 6 hours postinfec-
tion (hpi) (Changotra et al., 2009). Treatment with IFNg did not
alter this initial burst of viral protein synthesis in either control
or Atg5-deficient cells (Figure 7B). Of note, early synthesis of viral
proteins was detected even after pretreatment with 1000 U/ml of
IFNg treatment (Figure S5B) or in the presence of 200 U/ml of
IFNg throughout the course of infection (data not shown),
demonstrating that detection of normal levels of polymerase
expression at early time points was not due to insufficient
amounts of IFNg. These data further indicated that the initial
steps in MNV infection are not altered by IFNg although it isCell Host & Microbe 11blocked by IFNb (Changotra et al., 2009). It has
been reported that autophagy increases the
degradation of herpesvirus proteins in interferon
treated cells (Levine et al., 2011). Thus, we
examined the stability of the MNV polymerase
in control cells treated with IFNg. We allowed
infection to proceed to a point at which poly-
merase was expressed and then added cyclo-
heximide at a dose that prevents protein
synthesis (Figure S5C). When polymerase levels
were followed through the rest of the MNV repli-
cation cycle, there was no significant degrada-
tion of MNV polymerase in IFNg-treated control
cells (Figure S5D). In contrast to the lack of effect
on early steps in the MNV life cycle or poly-
merase stability, the increase in MNV poly-
merase expression observed 7–12 hr after
inoculation was inhibited by IFNg and this inhibi-
tion required Atg5 (Figure 7B).
We next examined the replication of viral
RNAs. Both positive-sense genomic and sub-
genomic RNAs were detected at 8 and 12 hpi
(Figure 7D). IFNg inhibited expression of bothpositive-sense genomes (encoding the polymerase protein and
other nonstructural proteins) and subgenomic RNAs (encoding
the capsid proteins) in an Atg5-dependent manner (Figure 7D).
Furthermore, IFNg inhibited expression of the negative-sense
viral RNA used as a template for positive-sense genomic and
subgenomic RNA transcription (Rohayem et al., 2006) in an
Atg5-dependent manner (Figure 7E). Consistently, the expres-
sion of MNV capsid protein, which is expressed after viral
replication, was inhibited by IFNg in an Atg5-dependent fashion
(Figure 7C). Viruses with single-strand positive-sense RNA
genomes, including MNV, form cytoplasmic membranous repli-
cation complexes for efficient generation of negative-sense and
positive-sense viral RNAs (Hyde et al., 2009; Wobus et al., 2004).
The MNV replication complex is a membranous structure
consisting of all MNV nonstructural proteins, including the viral
polymerase, as well as components from the ER, Golgi, and en-
dosomes, but not lysosomes (Hyde et al., 2009). Since IFNg
blocked synthesis of viral RNAs in an Atg5-dependent fashion
without effects on early steps in the viral life cycle, we examined
the effects of IFNg on the replication complex by analyzing the
subcellular distribution of the MNV polymerase. By 12 hr after
inoculation, we observed the MNV replication complex around
the nuclei of macrophages (Figure 7F). However, the formation, 397–409, April 19, 2012 ª2012 Elsevier Inc. 405
Figure 7. The Life Cycle of MNV that Is Suppressed by IFNg Dependently on Atg5
(A) Simple flow chart of the MNV life cycle.
(B) Western blot analysis of MNV polymerase expression in infected cells. A representative blot (n = 2) is shown.
(C) Western blot analysis of MNV capsid expression in infected cells. Samples used in (B) were reprobed with anti-VP1 (viral capsid) antibody.
(D) Northern blot analysis of genome and subgenome of MNV using RNA probe against viral capsid gene. GAPDH probe was used as loading control. A
representative blot (n = 3) is shown. The arrowhead indicates nonspecific signal.
(E) RNase protection assay of negative strand transcription of MNV. Lane 2 contains undigested MNV and GAPDH probe. RNA from mock-inoculated
macrophages served as a control (lane 3). A representative blot (n = 4) is shown.
(F) Immunofluorescence analysis of MNV (n = 3) using anti-propol antibody. Top: RepresentativeMNV replication complexes (403) in relation to nucleus. Bottom:
RepresentativeMNV replication complexes (203) at 12 hpi (MOI = 5) with (+IFNg) or without (–IFNg) pretreatment of 100 U/ml of IFNg. All images were taken using
the same settings.
See also Figure S5.
Cell Host & Microbe
Atg5-Atg12/Atg16L1 Complex in Antiviral Immunityof detectable MNV replication complexes was inhibited by treat-
ment with IFNg in an Atg5-dependent manner (Figure 7F), likely
explaining the effects of IFNg on subsequent steps in the viral
life cycle including production of infectious virus.
DISCUSSION
IFNg plays a major role in immune responses to infection but, in
contrast to its antibacterial and antiparasitic effects, the mecha-406 Cell Host & Microbe 11, 397–409, April 19, 2012 ª2012 Elseviernisms responsible for its direct antiviral effects against many
viruses are not understood. Here we report that a subset or
‘‘cassette’’ of the machinery involved in canonical autophagy is
essential for the antiviral effects of IFNg against MNV, a posi-
tive-sense single-stranded RNA virus within a genus including
the human pathogens responsible for the majority of epidemic
viral gastroenteritis world-wide. We found that expression of
Atg5 in macrophages and perhaps neutrophils is required for
resistance to MNV in the absence of the IFNab receptor,Inc.
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death and disease. This could be explained by the failure of
IFNg to control MNV replication in the macrophage in vivo, as
shown in our in vitro experiments. Alternatively, an independent
autophagy gene-dependent function of macrophages or neutro-
phils, such as secretion of cytokines (Saitoh et al., 2008; Dupont
et al., 2011), might play a determining role in MNV resistance.
In IFNg-activated macrophages, the Atg5-Atg12/Atg16L1
complex generated by Atg7 is responsible for blocking MNV
replication complex formation, explaining Atg5-dependent
effects on multiple subsequent steps in the viral life cycle
including synthesis of negative-sense RNAs, synthesis of posi-
tive-sense RNAs and viral structural proteins, and viral replica-
tion. Previous work from our laboratory (Wobus et al., 2004)
has shown that the membranous MNV replication complex is
morphologically quite distinct from autophagosomes. Unlike au-
tophagosomes, the replication complex contains complex
arrangements of convoluted and sometimes closely apposed
membranes without a concentric double membraned structure
or obvious intra-vesicular cytoplasmic contents or organelles.
Remarkably, extensive experiments detected no role for the
portion of the autophagy pathway downstream of Atg7 involving
Atg4B, lysosome-autophagosome fusion, or the degradative
function of the autophagy pathway, indicating that the host has
evolved to use specific portions or ‘‘cassettes’’ of the autophagy
machinery in host defense against specific pathogens. Analysis
of macrophage homeostasis, signaling, and gene expression
indicates that the role of the Atg5-Atg12/Atg16L1 proteins in
IFNg-mediated inhibition of MNV replication is posttranscrip-
tional. Previously, we and others have shown that Atg5 is
required not for the expression of, but for the recruitment of,
the IFNg-inducible p47 GTPase (IIGP1 or Irga6) to the parasito-
phorous vacuole membrane in order to clear Toxoplasma gondii
infection, without the apparent direct involvement of autophago-
somes (Zhao et al., 2008, 2009). Here we report a distinct role for
autophagy proteins comprising the Atg5-12/Atg16L1 complex in
IFNg-mediated alterations in intracellular membranes—in this
case preventing the formation of the membranous norovirus
replication complex. Collectively, these data support the
concept that the Atg5-12/Atg16L1 complex may function as
a versatile antipathogen module for IFNg-dependent blockade
of membrane rearrangements required for the replication of
certain pathogens.
While our studies did not detect a role for canonical autophagy
in IFNg-mediated control of MNV, the degradative effects of au-
tophagy play a key role in control of herpes simplex virus, Sindbis
virus infection, and human immunodeficiency virus (Kyei et al.,
2009; Orvedahl et al., 2007, 2010; Dreux and Chisari, 2010). In
fact, the degradative activity of the canonical autophagy
pathway likely contributes to many of the antipathogen roles of
autophagy proteins (Levine et al., 2011; Levine and Deretic,
2007; Dreux and Chisari, 2010). However, as shown here for
IFNg-mediated control of MNV replication, other studies also
support the concept that individual autophagy proteins or
cassettes of autophagy proteins may function in infection or
host defense in other ways. For example, autophagy proteins,
but not canonical autophagy, function in phagocytosis and
presentation of viral antigens to the immune system (Sanjuan
et al., 2007; Lee et al., 2010; Huang et al., 2009). Atg5 andCell HAtg7, but not canonical autophagy, are required for the secretory
function of osteoclasts, a macrophage-lineage cell type related
to themacrophages analyzed here (DeSelm et al., 2011). Further,
it has been reported that Atg5 can interact with IFNa/b-inducing
molecules RIG-I and IPS-1 to negatively regulate the IFNa/b
pathway and enhance viral infection (Levine et al., 2011). The au-
tophagy proteins Beclin-1, Atg4B, Atg5, and Atg12 have a role in
initiating infection with Hepatitis C virus (Dreux and Chisari,
2010). The formation of replicative compartments utilized by
Brucella abortus for generation of bacteria and cell-to-cell
spread is dependent on Atg14L1, Beclin-1, and ULK1 but inde-
pendent of Atg5, Atg7, and Atg16L1 (Starr et al., 2012). Similarly
LC3a and b, a subset of the autophagy pathway proteins, but not
Atg5 and Atg7, are required for coronavirus replication (Reggiori
et al., 2010; Zhao et al., 2007). Thus, proteins required for the
highly conserved and essential autophagy pathway likely have,
in addition to their essential role in degradative autophagy, key
independent roles in multiple aspects of infection and host
defense.
Since degradative autophagy is conserved in single-celled eu-
karyotic organisms, it is interesting to speculate that the multiple
roles of autophagy and autophagy proteins in host defense
reflects diversification of the physiologic roles of autophagy
and autophagy proteins as multicellular organisms developed
(Levine et al., 2011). In this way specific cassettes of autophagy
proteins could have developed additional functions important for
host defense. As a countermeasure, certain microorganisms
have evolved to co-opt cassettes of the autophagy machinery
to foster replication or spread within the host (Starr et al.,
2012). Targeting these individual cassettes of the autophagy
machinery to control specific infections without manipulating
a central process such as autophagy that plays such a key role
in cell and tissue homeostasis, may allow targeting of treatments
for while minimizing potentially deleterious side effects of antimi-
crobial therapy.
EXPERIMENTAL PROCEDURES
Mice and Cells
Atg5flox/flox and Atg7flox/flox mice were previously described (Zhao et al., 2008;
DeSelm et al., 2011). Atg16L1flox/flox mouse was generated using embryonic
stem cell line purchased from the European Conditional Mouse Mutagenesis
Program (EUCOMM) (unpublished data). All mice were housed and bred at
Washington University (St. Louis, MO) under specific-pathogen-free condi-
tions in accordance with federal and university guidelines as previously
described (Cadwell et al., 2010). 293T, RAW 264.7, and MEF cells were
used for production of lentiviruses, for plaque assay, and for immunofluores-
cence study, respectively. See the Supplemental Experimental Procedures
for the details and the generation of bone marrow-derived macrophages
(BMDMs).
Viruses and Infection
The following viruses were used for this study: MNV-1.CW3 (Thackray et al.,
2007), EMCV K strain, MHV A59 strain, and WNV North American isolate,
lineage 1 WNV strain 3000.0259. See the Supplemental Experimental Proce-
dures for the details of in vitro viral infection. For in vivo experiments, 6- to
8-week-old mice were orally inoculated with 3 3 104 pfu MNV and survival
was monitored for 30 days for three independent experiments. Statistical
significance was determined with a log-rank test. For quantification of tissue
viral burden, mice were sacrificed 5 days after inoculation. Organs were har-
vested and homogenized as previously described (Chachu et al., 2008) and
virus was titrated by plaque assay.ost & Microbe 11, 397–409, April 19, 2012 ª2012 Elsevier Inc. 407
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For identification of genes that are regulated by IFNg in an Atg5-
dependent manner, RNA collected from IFNg treated and untreated con-
trol and Atg5-deficient macrophages was profiled with Affymetrix Mouse
M430 2.0 (Figure 2A). The Gene Expression Omnibus accession number is
GSE34863. See the Supplemental Experimental Procedures for analysis
details.
Protein Analysis by Western Blot and Immunoprecipitation
Total cellular proteins were harvested with sample buffer (0.1 M Tris [pH 6.8],
4%SDS, 4mMEDTA, 286mM2-mercaptoethanol, 3.2M glycerol, 0.05%bro-
mophenol blue), and proteins were analyzed as previously described (Hwang
et al., 2009). For immunoprecipitation (IP), transfected 293T cells were lysed in
IP buffer (50 mM Tris [pH 7.5], 1% NP-40, 150 mM sodium chloride + protease
inhibitors) and subjected to IP with anti-FLAG antibody as previously
described (Hwang et al., 2009). See the Supplemental Experimental Proce-
dures for details.
Lentiviral Transduction
Modified lentiviral pCDH-MCS-T2A-copGFP-MSCV (System Biosciences,
Mountain View, CA; CD523A-1) vector was used as backbone to express
genes of interest. The T2A sequence in the vector is an 18 amino acid
sequence that enables self-cleavage during translation and allows simu-
ltaneous production of copGFP. Lentivirus was generated in 293T by
transfecting the lentiviral vector plasmids with packaging vector (psPAX2)
and pseudotyping vector (pMD2.G) using the calcium phosphate precipita-
tion method. Produced lentivirus was filtrated through 0.45 mm syringe
filter (Millipore, MA) and added onto BMDMs twice on day 3 and day 4 until
day 7.
Flow Cytometry and Immunofluorescence Analysis
Infected BMDMs were fixed at 12 hpi using 4% formaldehyde (Ted Pella, CA;
18505) for 10 min at room temperature (RT) and permeabilized with PBS/0.2%
TritionX-100 (PBSTX) for overnight at 4C. For flow cytometry, cells were
stained with rabbit anti-propol antibody and then DyLight 649 Donkey
anti-rabbit IgG (Biolegend, CA; 406406) in flow blocking buffer (PBS/0.2%
TritionX-100/1% normal goat serum/1% normal mouse serum). For immuno-
fluorescence, cells were stained with rabbit anti-propol antibody and then
Alexa Fluor 555 goat anti-rabbit antibody in blocking buffer (PBS/0.2%
TritionX-100/1% normal goat serum/10% normal mouse serum). See the
Supplemental Experimental Procedures for the details.
STORM Setup and Imaging
The STORM setup and imaging was similar to that described before (Dani
et al., 2010). See the Supplemental Experimental Procedures for details.
RNA Analysis by Northern Blot and RNase Protection Assay
BMDMs were incubated with IFNg (1 U/ml) or media alone for 12 hr then
infected with MNV at MOI = 5. Total RNAs were harvested at indicated
times with Trizol reagent (Invitrogen) according to manufacturer’s instruc-
tions. Northern blotting was performed using NorthernMax Kit (Applied
Biosytems; AM1940) according to manufacturer’s instruction. The synthesis
and/or accumulation of negative strand RNA was analyzed using two-cycle
RNase protection assay. See the Supplemental Experimental Procedures for
details.
Statistical Analysis
All data were analyzed with Prism software (GraphPad, San Diego, CA) with an
unpaired/paired t test or one-way analysis of variation (Tukey post test). All
differences not specifically stated to be significant were not significant
(p > 0.05).
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